The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Induction of Thrombosis in a Mouse Model by IgG, IgM and IgA Immunoglobulins from Patients with the Antiphospholipid Syndrome
Abstract
Antiphospholipid syndrome is a disorder of recurrent thrombosis and pregnancy losses associated with production of anticardiolipin antibodies and lupus anticoagulant positivity. Recently, we have adapted a mouse model of induced venous thrombosis to study the role of autoantibodies in thrombus formation. To determine whether immunoglobulins from patients with the antiphospholipid syndrome play a role in thrombosis, we injected groups of CDI mice either with immunoglobulins purified from seven patients with the antiphospholipid syndrome (nine preparations studied: four IgG, three IgM and two IgA) or with immunoglobulins of the same isotype from healthy controls. Seventy-two h after injection, a non-occlusive thrombus was induced in the femoral veins of experimental mice by a pinch injury; the thrombus areas as well as times of formation and disappearance of the thrombi were measured. Eight of the nine antiphospholipid syndrome immunoglobulin preparations caused a significant increase in mean thrombus area and a significant delay in mean thrombus disappearance time as compared with normal controls. To determine whether anticardiolipin antibodies might be involved, separate groups of mice were injected with affinity-purified IgG (n = 2) or IgM (n = 2) anticardiolipin antibodies or with normal immunoglobulins of the same isotype, and the effects on thrombus formation compared. Mean thrombus area and mean disappearance times were again significantly increased in all four groups injected with affinity-purified antibodies. This is the first study to show that anticardiolipin antibodies of IgG, IgM and IgA isotypes may play a role in thrombosis in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, elevated titres of IgA isotypes have been shown to be associated with thrombosis [10, 14–16].”
From Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus (2021) · cites this paper as [14]
Citations
Cites
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
Galli, M., Barbui, T., Comfurius, P., Maassen, C., Hemker, H. C., Zwaal, R. F. A., Bevers, E. M., Baets, M. H. D., & Vriesman, P. J. C. V. B. (1990) · The Lancet · doi:10.1016/0140-6736(90)91374-j · Cited by 1,266
Love, P. E., & Santoro, S. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-682 · Cited by 1,095
Thrombosis, Recurrent Fetal Loss, and Thrombocytopenia
Harris, E. N. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360230069012 · Cited by 546
Self-citationMatsuura, E., Igarashi, Y., Yasuda, T., Triplett, D. A., & Koike, T. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.2.457 · Cited by 528
Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis
Ginsburg, K. S., Liang, M. H., Newcomer, L., Goldhaber, S. Z., Schur, P. H., Hennekens, C. H., & Stampfer, M. J. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-997 · Cited by 526
The Catastrophic Antiphospholipid Syndrome
Rodríguez‐Pintó, I., Espinosa, G., & Cervera, R. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_20 · Cited by 493
Oosting, J. D., Derksen, R. H. W. M., Bobbink, I. W. G., Hackeng, T. M., Bouma, B. N., & de Groot, P. G. (1993) · Blood · doi:10.1182/blood.v81.10.2618.2618 · Cited by 487
Immunology and clinical importance of antiphospholipid antibodies
McNeil, H. P., Chesterman, C. N., & Krilis, S. A. (1991) · Advances in immunology · doi:10.1016/s0065-2776(08)60777-4 · Cited by 481
Blank, M., Cohen, J., Toder, V., & Shoenfeld, Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3069 · Cited by 453
Harris, E. N., Gharavi, A. E., & Hughes, G. R. V. (1985) · Clinics in Rheumatic Diseases · doi:10.1016/s0307-742x(21)00606-8 · Cited by 442
Self-citation
Cited by
Sorted by citations
Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
Holers, V. M., Girardi, G., Mo, L., Guthridge, J. M., Molina, H. D., Pierangeli, S. S., Espinola, R. G., Xiaowei, L. E., Mao, D., Vialpando, C. G., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.200116116 · Cited by 625
Self-citationRitis, K., Doumas, M. N., Mastellos, D. C., Micheli, A., Giaglis, S., Magotti, P., Rafail, S., Kartalis, G., Sideras, P., & Lambris, J. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4794 · Cited by 492
Pierangeli, S. S., Girardi, G., Vega-Ostertag, M. E., Liu, X., Espinola, R. G., & Salmon, J. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21157 · Cited by 362
Self-citationPierangeli, S. S., Colden‐Stanfield, M., Liu, X., Barker, J. H., Anderson, G. L., & Harris, E. N. (1999) · Circulation · doi:10.1161/01.cir.99.15.1997 · Cited by 323
Self-citationAntiphospholipid antibodies and thrombosis
Greaves, M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10362-8 · Cited by 300
Immunology of the antiphospholipid antibody syndrome
Roubey, R. A. S. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390903 · Cited by 300
Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management
Knight, J. S., Branch, D. W., & Ortel, T. L. (2023) · BMJ · doi:10.1136/bmj-2021-069717 · Cited by 299
Hydroxychloroquine Reverses Thrombogenic Properties of Antiphospholipid Antibodies in Mice
Edwards, M. H., Pierangeli, S., Liu, X., Barker, J. H., Anderson, G., & Harris, E. N. (1997) · Circulation · doi:10.1161/01.cir.96.12.4380 · Cited by 250
Self-citationCuadrado, M. J., López-Pedrera, C., Khamashta, M. A., Camps, M. T., Tinahones, F. J., Torres, A., Hughes, G. R. V., & Velasco, F. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400509 · Cited by 232
Camoin‐Jau, L., Sabatier, F., Arnoux, D., Anfosso, F. J., Bardin, N., Veit, V., Combes, V., Gentile, S., Moal, V., Sanmarco, M., et al. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-07-0487 · Cited by 228
Vega-Ostertag, M. E., Casper, K. A., Swerlick, R. A., Ferrara, D. E., Harris, E. N., & Pierangeli, S. S. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21009 · Cited by 228
Self-citationToll-like receptor and antiphospholipid mediated thrombosis: in vivo studies
Pierangeli, S. S., Vega-Ostertag, M. E., Raschi, E., Liu, X., Romay‐Penabad, Z., Micheli, V. D., Galli, M., Moia, M., Tincani, A., Borghi, M. O., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.065037 · Cited by 224
Self-citationHydroxychloroquine Reverses Platelet Activation Induced by Human IgG Antiphospholipid Antibodies
Espinola, R., Ghara, A., Harris, E., & Pierangeli, S. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613033 · Cited by 240
Self-citationAntiphospholipid syndrome and the skin
Gibson, G. E., Su, W. P. D., & Pittelkow, M. R. (1997) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(97)80283-6 · Cited by 187
Pierangeli, S. S., Espinola, R. G., Liu, X., & Harris, E. N. (2001) · Circulation Research · doi:10.1161/01.res.88.2.245 · Cited by 187
Self-citationLakos, G., Favaloro, E. J., Harris, E. N., Meroni, P. L., Tincani, A., Wong, R. C. W., & Pierangeli, S. S. (2011) · Arthritis & Rheumatism · doi:10.1002/art.33349 · Cited by 182
Self-citationPierangeli, S., de Groot, P. G., Dlott, J. S., Favaloro, E. J., Harris, E., Lakos, G., Ortel, T. L., Meroni, P. L., Otomo, K., Pengo, V., et al. (2011) · Lupus · doi:10.1177/0961203310395055 · Cited by 179
Self-citationJankowski, M., Vreys, I., Wittevrongel, C., Boon, D., Vermylen, J., Hoylaerts, M., & Arnout, J. (2002) · Blood · doi:10.1182/blood-2002-05-1310 · Cited by 175
Gharavi, A. E., Pierangeli, S. S., Espinola, R. G., Liu, X., Colden‐Stanfield, M., & Harris, E. N. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10130 · Cited by 174
Self-citationMcDonnell, T. C. R., Wincup, C., Buchholz, I., Pericleous, C., Giles, I., Ripoll, V. M., Cohen, H., Delcea, M., & Rahman, A. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100610 · Cited by 176
Bertolaccini, M. L., Amengual, O., Atsumi, T., Binder, W., de Laat, B., Forastiero, R. R., Kutteh, W. H., Lambert, M., Matsubayashi, H., Murthy, V. L., et al. (2011) · Lupus · doi:10.1177/0961203310397082 · Cited by 148
Self-citationFerrara, D. E., Liu, X., Espinola, R. G., Meroni, P. L., Abukhalaf, I. K., Harris, E. N., & Pierangeli, S. S. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11449 · Cited by 143
Self-citationBevers, E. M., Comfurius, P., & Zwaal, R. F. A. (1996) · Lupus · doi:10.1177/096120339600500531 · Cited by 140
Ferrara, D. E., Swerlick, R. A., Casper, K., Meroni, P. L., Vega-Ostertag, M. E., Harris, E. N., & Pierangeli, S. S. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00896.x · Cited by 139
Self-citationPathogenesis and management of antiphospholipid syndrome
Arachchillage, D. J., & Laffan, M. (2017) · British Journal of Haematology · doi:10.1111/bjh.14632 · Cited by 125
Pierangeli, S. S., Liu, X. W., Anderson, G., Barker, J. H., & Harris, E. N. (1996) · Circulation · doi:10.1161/01.cir.94.7.1746 · Cited by 118
Self-citationVega-Ostertag, M. E., Harris, E. N., & Pierangeli, S. S. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20434 · Cited by 118
Self-citationMurthy, V., Willis, R., Romay‐Penabad, Z., Ruiz‐Limón, P., Martínez‐Martínez, L. A., Jatwani, S., Jajoria, P., Seif, A., Alarcón, G. S., Papalardo, E., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38131 · Cited by 112
Self-citationDay, S. M., Reeve, J., Myers, D. D., & Fay, W. P. (2004) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613739 · Cited by 112
Seronegative antiphospholipid syndrome
Nayfe, R., Uthman, I. W., Aoun, J., Aldin, E. S., Merashli, M., & Khamashta, M. A. (2013) · Rheumatology · doi:10.1093/rheumatology/ket126 · Cited by 109
Arnout, J., & Vermylen, J. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00125.x · Cited by 107
Animal Models of Thrombosis From Zebrafish to Nonhuman Primates
Jagadeeswaran, P., Cooley, B. C., Gross, P. L., & Mackman, N. (2016) · Circulation Research · doi:10.1161/circresaha.115.306823 · Cited by 111
Gharavi, A. E., Pierangeli, S. S., Colden‐Stanfield, M., Liu, X. W., Espinola, R. G., & Harris, E. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2922 · Cited by 101
Self-citationPierangeli, S. S., Vega-Ostertag, M. E., & Harris, E. N. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.06.031 · Cited by 94
Self-citationE-Selectin mediates pathogenic effects of antiphospholipid antibodies
Espinola, R. G., Liu, X., Colden‐Stanfield, M., Hall, J., Harris, E. N., & Pierangeli, S. S. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00119.x · Cited by 91
Self-citationSevim, E., Zisa, D., Andrade, D., Sciascia, S., Pengo, V., Tektonidou, M. G., Ugarte, A., Gerosa, M., Belmont, H. M., Zamorano, M. A. A., et al. (2022) · Arthritis Care & Research · doi:10.1002/acr.24468 · Cited by 88
ANTIPHOSPHOLIPID ANTIBODY SYNDROME IN PEDIATRIC PATIENTS
Ravelli, A., & Martini, A. (1997) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70351-3 · Cited by 88
Pierangeli, S. S., Chen, P. P., & González, E. B. (2006) · Current Opinion in Internal Medicine · doi:10.1097/01.moh.0000239710.47921.d2 · Cited by 87
Self-citationNarshi, C. B., Giles, I., & Rahman, A. (2010) · Lupus · doi:10.1177/0961203310382429 · Cited by 83
Venous Thrombosis in the Antiphospholipid Syndrome
Farmer-Boatwright, M. K., & Roubey, R. A. S. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.182204 · Cited by 82
Zhu, M., Olee, T., Le, D. T., Roubey, R. A. S., Hahn, B. H., Woods, V. L., & Chen, P. P. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01292.x · Cited by 80
Olee, T., Pierangeli, S. S., Handley, H. H., Le, D., Wei, X., Lai, C.-J., En, J., Novotny, W. F., Harris, E. N., Woods, V. L., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8606 · Cited by 80
Self-citationAntiphospholipid antibodies and malignancies
Tincani, A., Taraborelli, M., & Cattaneo, R. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.04.001 · Cited by 76
Pericleous, C., Ruiz‐Limón, P., Romay‐Penabad, Z., Marin, A. C., Garza-Garcı́a, A., Murfitt, L., Driscoll, P. C., Latchman, D. S., Isenberg, D. A., Giles, I., et al. (2014) · Rheumatology · doi:10.1093/rheumatology/keu360 · Cited by 75
Self-citationMechanisms of autoantibody-mediated thrombosis
Roubey, R. A. S. (1998) · Lupus · doi:10.1177/096120339800700226 · Cited by 75
Soltész, P., Veres, K., Lakos, G., Kiss, E. V., Muszbek, L., & Szegedi, G. (2003) · Lupus · doi:10.1191/0961203303lu339oa · Cited by 72
Cucurull, E., Gharavi, A. E., Diri, E., Méndez, E., Kapoor, D., & Espinoza, L. R. (1999) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40573-7 · Cited by 71
Yang, Y.-H., Huang, M.-T., Lin, S.-C., Lin, Y.-T., Tsai, M.-J., & Chiang, B. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01361.x · Cited by 70
Antiphospholipid syndrome: From pathogenesis to novel immunomodulatory therapies
Comarmond, C., & Cacoub, P. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.12.006 · Cited by 69
Thrombogenesis with continuous blood flow in the inferior vena cava
Hawley, A. E., Alvarado, C. M., Berguer, A., Baker, N., Wrobleski, S. K., Wakefield, T. W., Lucchesi, B. R., Myers, D. D., & Diaz, J. A. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-09-0672 · Cited by 68
Romay‐Penabad, Z., Liu, X., Montiel-Manzano, G., de Martinez, E. P., & Pierangeli, S. S. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1422.058 · Cited by 68
Self-citationMontiel-Manzano, G., Romay‐Penabad, Z., de Martinez, E. P., Meillón‐García, L. A., Garcı́a-Latorre, E., Reyes‐Maldonado, E., & Pierangeli, S. S. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1422.057 · Cited by 67
Self-citationLee, R. M., Branch, D. W., & Silver, R. M. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.117659 · Cited by 67
Austin, A., Campbell, E., Lane, P., & Elias, E. (2004) · Gut · doi:10.1136/gut.2003.036806 · Cited by 66
Meant to B: B cells as a therapeutic target in systemic lupus erythematosus
Atisha‐Fregoso, Y., Toz, B., & Diamond, B. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149095 · Cited by 68
In Vivo Models of Thrombosis for the Antiphospholipid Syndrome
Pierangeli, S., & Harris, E. N. (1996) · Lupus · doi:10.1177/096120339600500524 · Cited by 65
Self-citationBevers, E. M., Comfurius, P., Dekkers, D. W. C., Harmsma, M., & Zwaal, R. F. A. (1998) · Lupus · doi:10.1177/096120339800700228 · Cited by 65
C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies
Carrera‐Marin, A. L., Romay‐Penabad, Z., Papalardo, E., Reyes‐Maldonado, E., Garcı́a-Latorre, E., Vargas, G., Shilagard, T., & Pierangeli, S. S. (2012) · Lupus · doi:10.1177/0961203312458839 · Cited by 61
Self-citationComplement Activation: A Novel Pathogenic Mechanism in the Antiphospholipid Syndrome
Pierangeli, S. S., Vega-Ostertag, M. E., Liu, X., & Girardi, G. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1361.083 · Cited by 64
Self-citationDiri, E., Cucurull, E., Gharavi, A. E., Kapoor, D., Mendez, E. A., Scopelitis, E., & Wilson, W. (1999) · Lupus · doi:10.1191/096120399678847812 · Cited by 61
Pietté, J. C. (1996) · Lupus · doi:10.1177/096120339600500504 · Cited by 61
Clinical Significance of IgA Anti-Cardiolipin and IgA Anti-β2Glycoprotein I Antibodies
Andréoli, L., Fredi, M., Nalli, C., Piantoni, S., Reggia, R., Dall’Ara, F., Franceschini, F., & Tincani, A. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0343-1 · Cited by 59
Cofactor‐independent human antiphospholipid antibodies induce venous thrombosis in mice
Manukyan, D., Müller‐Calleja, N., Jäckel, S., Luchmann, K., Mönnikes, R., Kiouptsi, K., Reinhardt, C., Jurk, K., Walter, U., & Lackner, K. J. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13263 · Cited by 58
Animal models of venous thrombosis
Albadawi, H., Witting, A., Pershad, Y., Wallace, A., Fleck, A., Hoang, P., Khademhosseini, A., & Öklü, R. (2017) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2017.08.10 · Cited by 57
Statins for the Treatment of Antiphospholipid Syndrome?
Jajoria, P., Murthy, V. L., Papalardo, E., Romay‐Penabad, Z., Gleason, C. E., & Pierangeli, S. S. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04815.x · Cited by 55
Self-citationExperimental Thrombosis and Antiphospholipid Antibodies: New Insights
Pierangeli, S. S., Gharavi, A. E., & Harris, E. N. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0420 · Cited by 56
Self-citationFerric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel
Bonnard, T., & Hagemeyer, C. E. (2015) · Journal of Visualized Experiments · doi:10.3791/52838 · Cited by 65
Antiphospholipid antibodies in thromboangiitis obliterans
Masłowski, L., McBane, R. D., Alexewicz, P., & Wysokiński, W. E. (2002) · Vascular Medicine · doi:10.1191/1358863x02vm452oa · Cited by 54
Dombroski, D. G., Balasubramanian, K., & Schroit, A. J. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0365 · Cited by 53
A novel mechanism of thrombosis in antiphospholipid antibody syndrome
Vlachoyiannopoulos, P. G., & Routsias, J. G. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.06.015 · Cited by 52
Pierangeli, S. S., Blank, M., Liu, X., Espinola, R. G., Fridkin, M., Vega-Ostertag, M. E., Roye-Green, K. J., Harris, E. N., & Shoenfeld, Y. (2004) · Journal of Autoimmunity · doi:10.1016/j.jaut.2004.01.002 · Cited by 52
Self-citationMisasi, R., Capozzi, A., Longo, A., Recalchi, S., Lococo, E., Alessandri, C., Conti, F., Valesini, G., & Sorice, M. (2015) · Journal of Immunology Research · doi:10.1155/2015/858542 · Cited by 51
Clinical laboratory testing for the antiphospholipid syndrome
Pierangeli, S. S., & Harris, E. N. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.02.002 · Cited by 49
Self-citationAntiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future
Mehdi, A. A., Uthman, I. W., & Khamashta, M. A. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02281.x · Cited by 47
Laboratory diagnosis and management challenges in the antiphospholipid syndrome
Bertolaccini, M. L., & Khamashta, M. A. (2006) · Lupus · doi:10.1191/0961203306lu2293rr · Cited by 47
Antiphospholipid (Hughes) Syndrome
Khamashta, M. A., Bertolaccini, M. L., & Hughes, G. R. V. (2004) · Autoimmunity · doi:10.1080/08916930410001708706 · Cited by 44
A murine model of deep vein thrombosis Characterization and validation in transgenic mice
Szema, L., Chen, C.-Y., Schwab, J. P., Schmeling, G. J., & Cooley, B. C. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-03-0170 · Cited by 43
Ethnic and geographical variation in antiphospholipid (Hughes) syndrome
Uthman, I. W., & Khamashta, M. A. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.038448 · Cited by 43
Diagnosis of antiphospholipid syndrome
Bertolaccini, M. L., Khamashta, M. A., & Hughes, G. R. V. (2005) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0017 · Cited by 40
Carmo-Pereira, S., Bertolaccini, M. L., Escudero‐Contreras, A., Khamashta, M. A., & Hughes, G. R. V. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.6.540 · Cited by 41
Elevated serum IgA anticardiolipin antibody levels in adult Henoch-Schönlein purpura
Kawakami, T., Watabe, H., Mizoguchi, M., & Soma, Y. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07457.x · Cited by 40
Misasi, R., Longo, A., Recalchi, S., Caissutti, D., Riitano, G., Manganelli, V., Garofalo, T., Sorice, M., & Capozzi, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218411 · Cited by 40
IgA antiphospholipid antibodies are an independent risk factor for thromboses
Shen, Y., Lee, R., Frenkel, E., & Sarode, R. (2008) · Lupus · doi:10.1177/0961203308093460 · Cited by 39
Antiphospholipid Syndrome: A Comprehensive Clinical Review
Patriarcheas, V., Tsamos, G., Vasdeki, D., Kotteas, E. A., Κόλλιας, Α., Nikas, D. J., Kaiafa, G. D., & Dimakakos, E. P. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030733 · Cited by 46
Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis
Diaz, J. A., Wrobleski, S. K., Hawley, A. E., Lucchesi, B. R., Wakefield, T. W., & Myers, D. D. (2011) · Journal of Visualized Experiments · doi:10.3791/2737 · Cited by 39
The antiphospholipid syndrome – often overlooked cause of vascular occlusions?
Svenungsson, E., & Antovič, A. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13022 · Cited by 39
Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus
Demir, S., Li, J., Magder, L. S., & Petri, M. (2021) · Rheumatology · doi:10.1093/rheumatology/keaa857 · Cited by 39
Kumar, S., Papalardo, E., Sunkureddi, P. R., Najam, S., González, E., & Pierangeli, S. (2009) · Lupus · doi:10.1177/0961203309103048 · Cited by 38
Self-citationDomingues, V., Magder, L. S., & Petri, M. (2016) · Lupus Science & Medicine · doi:10.1136/lupus-2015-000107 · Cited by 36
Yang, Y., Hwang, K., FitzGerald, J. D., Grossman, J. M., Taylor, M. B., Hahn, B. H., & Chen, P. P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8219 · Cited by 36
Testing for Antiphospholipid Antibodies: Problems and Solutions
Pierangeli, S. S., Gharavi, A. E., & Harris, E. N. (2001) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-200103000-00007 · Cited by 36
Self-citationAnti‐β2‐glycoprotein I antibodies
Willis, R., & Pierangeli, S. S. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12080 · Cited by 34
Self-citationOrdi‐Ros, J. (2001) · Scandinavian Journal of Rheumatology · doi:10.1080/030097401316909594 · Cited by 34
Towards improved criteria for the antiphospholipid syndrome
Pietté, J. C. (1998) · Lupus · doi:10.1177/096120339800700233 · Cited by 34
Antiphospholipid antibodies: biological basis and prospects for treatment
Chamley, L. (2002) · Journal of Reproductive Immunology · doi:10.1016/s0165-0378(02)00041-4 · Cited by 33
THROMBOTIC SYNDROMES AND AUTOIMMUNE DISEASES
Fessler, B. J. (1997) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70340-9 · Cited by 33
In vivo monitoring of venous thrombosis in mice
Aghourian, M. N., Lemarié, C. A., & Blostein, M. D. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04615.x · Cited by 32
Gharavi, A. E., Pierangeli, S. S., Gharavi, E. E., Hua, T., Liu, X. W., Barker, J. H., Anderson, G. H., & Harris, E. N. (1998) · Lupus · doi:10.1191/096120398678920190 · Cited by 32
Self-citationCabrera-Marante, Ó., de Frías, E. R., Serrano, M., Lozano, F., Naranjo, L., Gil‐Etayo, F. J., Paz‐Artal, E., Pleguezuelo, D. E., & Serrano, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238972 · Cited by 32
The Role of Complement in the Antiphospholipid Syndrome: A Novel Mechanism for Pregnancy Morbidity
Samarkos, M., Mylona, E. E., & Kapsimali, V. (2012) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2012.01.001 · Cited by 31
Metadata
- Authors
- Pierangeli, S. S., Liu, X. W., Barker, J. H., Anderson, G., & Harris, E. N.
- Affiliations
- The Antiphospholipid Standardization Laboratory, Louisville, KY, USA
- The Department of Medicine, Division of Rheumatology, Louisville, KV, USA
- The Department of Surgery, Louisville, KY, USA
- University of Louisville (US)
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 1995
- Volume
- 74
- Issue
- 05
- Pages
- 1361-1367
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W167774609
- Cited by
- 223
- References
- 45
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 7 · 2023: 2 · 2022: 5 · 2021: 2 · 2020: 8 · 2019: 7 · 2018: 4 · 2017: 7 · 2016: 10 · 2015: 4 · 2014: 4 · 2013: 9 · 2012: 13
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thrombosis and Haemostasis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- antiphospholipid syndrome, anticardiolipin antibodies, thrombosis, IgG, immunoglobulin M, immunoglobulin A, autoantibodies, venous thrombosis, mouse model, ICR mice, lupus anticoagulant, thrombus formation
- MeSH terms
- Animals, Femoral Vein, Humans, Immunoglobulin A, Immunoglobulin G, Immunoglobulin M, Immunization, Passive, Male, Thrombosis, Antiphospholipid Syndrome, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
